.png)
“The Great Eight”
Resident Presentation & Awards Program
Wednesday, June 18, 2025; 5pm - 8pm EDT
2 hours of live ACPE credit available
Hosted at University of Saint Joseph
1678 Asylum Ave, West Hartford, CT 06117
Member and Non-Members - $25
Incoming 2025-2026 CT PGY1 and PGY2 residents: Free
Registration Closes: June 6th
Payment Due: June 10th
REGISTER TODAY!ABOUT THE GREAT EIGHT
Join us for our annual, juried showcase of the work of Connecticut Pharmacy Residents. The Great Eight is an opportunity for Connecticut's Pharmacy Residents to present their research in front of clinical pharmacists and pharmacy administrators who are interested in the work that they have completed.
RETURNING FOR 2025
The Great Eight was introduced in 2012 to spotlight the work of CSHP's Resident Members. As of 2024, CSHP decided to open the Great Eight to all Residents in the state of Connecticut and the winning eight will receive a one year complimentary CSHP Resident Membership.
This event will offer 2 live ACPE credit hours for pharmacists and pharmacy technicians approved & accredited by the Hartford Healthcare as a provider of continuing pharmacy education for both pharmacists and pharmacy technicians.
ABSTRACTS
Submissions are due Wednesday May 7th, 2025
PARKING & DRECTIONS:
DON'T FORGET
UPDATE YOUR MEMBERSHIP profile/level to match your upcoming student or professional role.
Congratulations to the 2025 Great Eight Presenters!
Kaitlyn Adams
Objective: Evaluate the impact of time of administration, age, biological sex, weight, race, and ethnicity on progression-free survival in patients receiving an immune checkpoint inhibitor for stage III or IV non-small cell lung cancer
Alina Chykharivska
Title: Real-World Safety and Tolerability of Teclistamab and Talquetamab for Management of Relapsed and Refractory Multiple Myeloma
Objective: To determine the incidence and severity of CRS and ICANS seen with teclistamab and talquetamab in the real-world population and to assess safety of abbreviated step-up dosing
Haley Guarriello
Objective: Examine the safety and efficacy outcomes of patients with traumatic intracranial hemorrhage on P2Y12 inhibitors who received desmopressin versus those who did not
Hannah McDermott
Objective: Evaluate safety of anticoagulation in post operative cardiac patients with atrial fibrillation
Nina Mirontchik
Objective: Describe buprenorphine’s role in analgosedation compared to full mu-opioid agonists in patients in the intensive care unit
Ellie Ouellette
Objective: At the conclusion of my presentation, the participant will be able to describe the impact of an embedded 4T scoring clinical decision support tool to the electronic medical record on HIT diagnostic testing
Rebecca Vales
Objective: Describe the relationship between intravenous magnesium dosing and the change in serum magnesium levels, while identifying clinical factors that influence this response in critically ill patients
Mariam Zedan
Objective: Describe the role of pharmacists and pharmacy technicians in addressing medication affordability barriers